Exposure to antibiotic treatment, both prenatal and in the first year of a child’s life, may increase the risk of developing type 1 diabetes before the age of ten, a Swedish study has found. A possible cause is that antibiotics can create alterations in the gut microbiome composition, and subsequently affect the immune system’s development. […]
People with diabetes are more susceptible to oral and vulvovaginal candidiasis, fungal infections caused by the Candida yeast. The elevated glucose levels in diabetes help Candida flourish, which makes patients more vulnerable to both oral and vaginal infections than people without diabetes. Read more
During the COVID-19 pandemic, more hospitals moved to using continuous glucose monitors (CGM) for hospitalized diabetes patients. Using CGM rather than fingersticks lessens healthcare workers’ need to use personal protective equipment (PPE) to monitor patients’ blood sugar. Researchers are using this opportunity to evaluate the accuracy and effectiveness of CGMs used in a hospital setting. […]
The COVID-19 pandemic has made managing their diabetes more difficult for many Americans, new research says. 19% of Americans with diabetes skipped at least one medical appointment due to fear of contracting the virus. Almost a quarter say that managing their diabetes has been difficult due to the pandemic, while 17% say they have developed […]
While insulin is the standard treatment for type 1 diabetes, it is also used for type 2 diabetes patients who are unable to reach their glycemic target with other medications. As the number of patients with type 2 prescribed insulin is growing, researchers sought to understand whether the risk for hypoglycemia associated with insulin could […]
People with diabetes are vulnerable to strokes, which can cause disability or death. Dr. Richard Benson explains some of the links between strokes and diabetes, and how reducing your blood A1C levels, high blood pressure, and high cholesterol can help reduce your stroke risk. Read more
Indexes of insulin sensitivity are a practical method for assessing type 2 diabetes risk without more complicated tests. However, while studies have compared the effectiveness of various indexes in predicting type 2 diabetes in whites, African Americans, Hispanic Americans, and other ethnicities, studies among the Asian population have been lacking. Read more
Researchers at University of California San Diego School of Medicine say they have identified specific cell types that can contribute to causing type 1 diabetes. The researchers made their findings through mapping details of how and when genes are turned on and off in cells, which affects production of proteins needed for specific cellular functions. […]
A new study conducted among 4,000 young men who had a stutter, between the ages of 16- and 20-years old, and living in Israel, found that teenagers who stutter may have a higher likelihood of developing early-onset type 2 diabetes. One explanation is that the anxiety a person may experience about their speech impediment could […]
Advances in diabetes technology, like CGMs and automated insulin delivery systems, are associated with improved outcomes for people with diabetes. However, some people have been less likely to make use of these technologies, possibly due to factors of cost, socioeconomic background, or racial disparities. A large study examines the barriers to using diabetes tech. Read […]
TTP399 is a potential new oral medication to lower and stabilize blood glucose in people with type 1 diabetes (T1D). If approved, TTP399 will be the first oral pill to treat T1D. In conjunction with insulin TTP399 should lower blood glucose without raising the risk of either diabetic ketoacidosis (DKA) or low blood glucose. Diabetes […]
Some regional diets, like the Mediterranean diet, have been shown to be more beneficial for diabetes patients than the standard American diet. Nutrition professionals are now looking more closely at the health benefits of other traditional and heritage diets, to better support the physical and quality of life needs of diverse diabetes patients. Read more
Metabolic syndrome encompasses several cardiovascular risk factors, including abdominal obesity, dyslipidemia, hypertension, insulin resistance, and prothrombic and proinflammatory states. Metabolic syndrome has long been associated with type 2 diabetes and insulin resistance; however, with rising obesity rates, an association between metabolic syndrome and type 1 diabetes has also developed. Read more
Atrial fibrillation can be detected during annual foot assessments in patients with diabetes who had not previously been diagnosed with the heart arrhythmia, according to research presented at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC). The researchers found that one in six patients with diabetes had previously undiagnosed atrial […]
Many patients with chronic kidney disease are at a higher risk for severe kidney and heart health issues. The DAPA-CKD trial was designed to see the impact of Dapagliflozin Propanediol, which is sold under the brand name Farxiga, in patients with and without type 2 diabetes who had chronic kidney disease. Read more
Healthcare providers need to do more to bring young Black and Hispanic patients with type 1 diabetes into a shared decision-making process, a recent study says. Improving shared decision-making could help reduce racial-ethnic inequity in use of diabetes technology. Read more
A recent study examined whether there were differences in the risk of myocardial infarction between men and women. The study included participants with different diabetes statuses and different A1C levels, using data from 471,399 participants in the U.K. Biobank between 2006 and 2010. Read more
It’s estimated that in 2017, 1 out of every 7 dollars spent on healthcare in the US was spent on diabetic care, and 45 percent of spending was on medications and supplies. This burden has only increased for many people, as the cost of medications like insulin continue to rise. There are many programs aimed […]
Hyperglycemia has long been associated with risks to cognitive function in people with diabetes. Now a new analysis suggests that patients with prediabetes have a similar risk for declines in brain function to patients already diagnosed with diabetes, making good glucose control important in the prediabetes stage. Read more
Several pharma companies withdrew from the US Federal government’s 340B drug pricing program last fall, which has left many patients with diabetes struggling to cope with surging insulin prices, or having to use less effective versions of insulin, says Anne Webster, NP. Read more